首页/数据集/FDA-registered trials and corresponding publications for cohort of 4 newer antidepressants.

FDA-registered trials and corresponding publications for cohort of 4 newer antidepressants.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/FDA-registered_trials_and_corresponding_publications_for_cohort_of_4_newer_antidepressants_/18731086 数据链接链接失效反馈

官方服务：

资源简介：

FDA-registered trials and corresponding publications for cohort of 4 newer antidepressants.

应用场景：

创建时间：

2022-01-19

药物开发

FDA美国食品药品监督管理局

Data extracted from press releases and news articles announcing breakthrough therapy designations. Contains a nearly-complete list of Breakthrough Therapy Designations as of July 31, 2018.

DataCite Commons2020-08-26 更新40

Replication data for: FDA Deadlines Study 2011

FDA美国食品药品监督管理局

行政管理

Public agencies have discretion on the time domain, and politicians deploy numerous policy instruments to constrain it. Yet little is known about how administrative procedures that affect timing also

DataONE2015-04-11 更新30

Dataset from A Phase 3, Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 (15 and 20 mg) in Subjects With Major Depressive Disorder

抑郁症药物临床试验

治疗安全性评估

The purpose of this study is to determine the long-term safety and tolerability of vortioxetine, once daily (QD), in participants with major depressive disorder.

NIAID Data Ecosystem00

Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels

药物安全监测

FDA美国食品药品监督管理局

Comparing the safety of prescription drugs over time is difficult due to the paucity of reliable quantitative measures of drug safety. Both the academic literature and popular press have focused on dr

NBER2006-12-01 更新40

Available IPD datapackage for study 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (25 and 50 mg/Day) of DVS SR Tablets in Adult Outpatients With Major Depressive Disorder'

抑郁症药物临床试验

患者结局评估

The primary purpose of this study is to compare the antidepressant efficacy and safety of two doses of DVS SR (25 and 50 mg/day) in the treatment of adults with Major Depressive Disorder. The study wi

DataCite Commons2024-12-02 更新00

FDA-registered trials and corresponding publications for cohort of 4 newer antidepressants.

资源简介：

相关数据集